ZELIRA THERAPEUTICS LIMITED

2.46%

62.5¢

Market Cap $7.257M

Healthcare Biotechnology

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Latest Threads

Tag

Subject

ZLD

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

29/01/26

330

29/01/26

Last post Mcdunk

330

ZLD

Ann: Transformative US$33M Fundraising into Zeliras HOPE 1 SPV

19/01/26

10K

19/01/26

Last post CrispyPork777

10K

ZLD

Happy New Year

02/01/26

238

02/01/26

Last post Mcdunk

238

ZLD

ZLD vs NTI autism

23/12/25

783

23/12/25

Last post Mcdunk

783

ZLD

Ann: Change of Director's Interest Notice x2

04/12/25

222

04/12/25

Last post

ASX News

222

ZLD

Ann: Notification regarding unquoted securities - ZLD

04/12/25

190

04/12/25

Last post

ASX News

190

ZLD

Ann: Proposed issue of securities - ZLD

01/12/25

1.0K

01/12/25

Last post jcurve

1.0K

ZLD

Ann: Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund

25/11/25

213

25/11/25

Last post

ASX News

213

See All Discussions

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
29 Jan 09:25	Share

Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
16 Jan 10:03	Share

Change of Director's Interest Notice x2
04 Dec 20:06	Share

Notification regarding unquoted securities - ZLD
04 Dec 20:03	Share

Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
25 Nov 14:33	Share

Proposed issue of securities - ZLD
19 Nov 15:27	Share

Results of Meeting
19 Nov 14:40	Share

2025 Annual General Meeting Presentation
19 Nov 12:03	Share

Quarterly Activities/Appendix 4C Cash Flow Report
27 Oct 14:33	Share

Notification of cessation of securities - ZLD
22 Oct 12:31	Share

Letter to Shareholders
20 Oct 16:21	Share

Notice of Annual General Meeting/Proxy Form
20 Oct 16:21	Share

Appendix 4G
26 Sep 12:20	Share

Annual Report to shareholders
26 Sep 12:19	Share

AGM Date and Closing Date for Director Nominations
23 Sep 16:21	Share

Director Loans
16 Sep 11:58	Share

Preliminary Final Report
29 Aug 14:00	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 16:29	Share

Zelira Therapeutics Secures R&D Loan Facility
24 Jul 12:05	Share

Publication of ZLT-L-007 IRB Approved Observational Study
22 May 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
29 Apr 11:06	Share

Full Conversion of $USD3.25M Convertible Notes in HOPE SPV
28 Apr 08:23	Share

Investor Presentation
03 Apr 08:17	Share

Application for quotation of securities - ZLD
01 Apr 17:49	Share

Cleansing Prospectus
31 Mar 13:07	Share

Proposed issue of securities - ZLD
31 Mar 12:33	Share

Zelira secures $1 Million At-the-Market Funding Facility
31 Mar 08:18	Share

Appendix 4D & FY25 Interim Financial Report
26 Feb 20:14	Share

Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund
18 Feb 13:32	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 62.5¢		Change 0.015(2.46%)		Mkt cap ! $7.257M

Open	High	Low	Volume
62.0¢	62.5¢	62.0¢	6.196K

Buyers (Bids)

Vol.	Price($)
5967	63.0¢

Sellers (Offers)

Price($)	Vol.
65.0¢	3168

Last trade - 16.06pm 09/02/2026 (20 minute delay)

ZLD (ASX) Chart

ZELIRA THERAPEUTICS LIMITED

Latest Threads

LM1 Strikes High-Grade Gold at Evanston, Growth Potential Builds

Timeline

Featured News

Latest Videos

Zelira Therapeutics (ASX:ZLD) raises $1.77m through US-based investors

15 Mar 2023 14:06 (AEDT)

Latest Articles

Zelira Therapeutics (ASX:ZLD) promotes Greg Blake as Executive Director

Zelira Therapeutics (ASX:ZLD) has promoted Greg Blake from VP - Global Head ofCommercial and Partnering to Executive Director.

Zelira Therapeutics (ASX:ZLD) secures US$8.6m in funding for HOPE clinical trials

Zelira Therapeutics (ASX:ZLD) has secured US$8.6 million (A$12.3 million) in cornerstone funding from a US-based investor to support its HOPE clinical trials.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News